COMMUNIQUÉS West-GlobeNewswire

Diversicare Completes Transaction to Exit the State of Kentucky
05/09/2019
BRENTWOOD, Tenn., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (OTCQX: DVCR) today announced that effective August 30, 2019 it completed the transaction to transfer the operations of ten [...]
AMAG Urges Stockholders to Take No Action on Caligan Partners’ Consent Solicitation Materials
04/09/2019
WALTHAM, Mass., Sept. 04, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) (“AMAG” or the “Company”) today responded to the preliminary consent solicitation filed by Caligan Partners (“Caligan”) with [...]
James Hyman Joins Corizon Health as Chief Executive Officer
04/09/2019
BRENTWOOD, Tenn., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Corizon Health today announced the appointment of James E. Hyman as Chief Executive Officer effective Sept. 1. “James brings a unique set of skills and experiences to [...]
ContraFect to Present at the 2019 Janney Healthcare Conference
04/09/2019
YONKERS, New York, Sept. 04, 2019 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX) , a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including [...]
Agios Announces Publication of Data for Mitapivat from Core and Extension Phases of the DRIVE PK Study in Patients with Pyruvate Kinase Deficiency in the New England Journal of Medicine
04/09/2019
– Maximum Hemoglobin Increases >1.0 g/dL Observed in 50% of Patients in Core Period, Among Whom the Mean Maximum Hemoglobin Increase was 3.4 g/dL – – Hemoglobin Responses Maintained in 19 Patients in the Extension [...]
Harvard Bioscience Elects Alan Edrick to Board of Directors
04/09/2019
HOLLISTON, Mass., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that its Board of Directors has elected Alan Edrick to Harvard Bioscience’s Board of Directors, effective [...]
Harvard Bioscience to Present at Janney Healthcare Conference
04/09/2019
HOLLISTON, Mass., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced that Chairman, President and CEO, Jim Green, will be presenting at the Janney Montgomery Scott Healthcare Conference [...]
Scholar Rock to Present at Upcoming Healthcare Conferences
04/09/2019
CAMBRIDGE, Mass., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Scholar Rock Holding Corporation (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth [...]
Avid Bioservices Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
04/09/2019
TUSTIN, Calif., Sept. 04, 2019 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives [...]
Adverum Biotechnologies to Host a Conference Call and Webcast to Present 24-week Data from First Cohort of OPTIC Trial of ADVM-022 Intravitreal Injection Gene Therapy to Treat Wet AMD at Retina Society 2019 Annual Meeting
04/09/2019
-- Podium presentation of 24-week data from first cohort of the OPTIC trial at Retina Society 2019 Annual Meeting on September 12, 2019 at 7:41 am BST -- -- Adverum to host a conference call and webcast to review the [...]
WeedMD Announces $10 Million Bought Short Form Prospectus Offering of Convertible Debenture Units
04/09/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Sept. 04, 2019 (GLOBE NEWSWIRE) -- WeedMD Inc. (“ WeedMD ” or the “ Company ”) (TSXV:WMD) is pleased to announce that is has [...]
Oncology Venture provides further information on the terms for a proposed rights issue
04/09/2019
Press release Hoersholm, Denmark, September 4, 2019 – Oncology Venture A/S (Nasdaq First North Growth Market Stockholm: OV.ST) hereby provides clarification on the terms for the proposed rights issue, that was announced [...]
Oasmia completes its management team
04/09/2019
Oasmia has further strengthen its management team with the recruitment of two General Managers to accelerate commercialization of Oasmia. Neil Yman is appointed General Manager for Europe & Russia and Reinhard [...]
NNPBC Welcomes New Executive Director
04/09/2019
BURNABY, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Nurses and Nurse Practitioners of BC (NNPBC) is pleased to welcome Michael Sandler RN, MSN to the role of Executive Director beginning September 23 rd , 2019. “Michael is a [...]
Announcement About Convening of the Extraordinary General Meeting of Shareholders of Joint Stock Company “Olainfarm”
04/09/2019
Announcement About Convening of the Extraordinary General Meeting of Shareholders of Joint Stock Company “Olainfarm” Management Board of the Joint Stock Company Olainfarm, unitary registration number: 40003007246, [...]
Notice on additional agenda items for Extraordinary General Meeting of shareholders of Joint Stock Company Olainfarm to be held on November 1th, 2019 at 11:00
04/09/2019
Notice on additional agenda items for Extraordinary General Meeting of shareholders of Joint Stock Company Olainfarm to be held on November 1th, 2019 at 11:00 Joint Stock Company Olainfarm (unitary registration No. [...]
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2019
04/09/2019
Disclosure of Share Capital and Voting Rights Outstanding as of August 31, 2019 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
EssilorLuxottica : Nombre total de droits de vote et d’actions composant le capital social au 31 août 2019
04/09/2019
Nombre total de droits de vote et d’actions composant le capital social au 31 août 2019 (Conformément à l’article L.233-8 II du Code de Commerce et aux articles 221-1 et 223-16 du Règlement Général de l’AMF) Charenton- [...]
Inventiva achieves a major milestone by completing patient recruitment for its Phase IIb clinical study with lanifibranor in NASH
04/09/2019
Last patient randomized in the Phase IIb NATIVE trial evaluating lanifibranor in NASH patients 247 patients randomized in the study, exceeding the initial target of 225 patients Publication of the study results expected [...]

Pages